These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


351 related items for PubMed ID: 18490064

  • 1. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
    Pillay NS, Kellaway LA, Kotwal GJ.
    Behav Brain Res; 2008 Oct 10; 192(2):173-7. PubMed ID: 18490064
    [Abstract] [Full Text] [Related]

  • 2. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.
    Kulkarni AP, Pillay NS, Kellaway LA, Kotwal GJ.
    Biogerontology; 2008 Dec 10; 9(6):405-20. PubMed ID: 18679819
    [Abstract] [Full Text] [Related]

  • 3. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP, Brown RE.
    Behav Brain Res; 2009 Jul 19; 201(1):120-7. PubMed ID: 19428625
    [Abstract] [Full Text] [Related]

  • 4. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 19; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 5. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI.
    Neuroscience; 2006 Sep 01; 141(3):1149-62. PubMed ID: 16753269
    [Abstract] [Full Text] [Related]

  • 6. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 7. Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.
    Frye CA, Walf AA.
    Neurobiol Learn Mem; 2008 Jan 23; 89(1):17-26. PubMed ID: 17988898
    [Abstract] [Full Text] [Related]

  • 8. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS.
    J Ethnopharmacol; 2011 Sep 01; 137(1):783-9. PubMed ID: 21762767
    [Abstract] [Full Text] [Related]

  • 9. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
    Heikkinen T, Kalesnykas G, Rissanen A, Tapiola T, Iivonen S, Wang J, Chaudhuri J, Tanila H, Miettinen R, Puoliväli J.
    Exp Neurol; 2004 May 01; 187(1):105-17. PubMed ID: 15081593
    [Abstract] [Full Text] [Related]

  • 10. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.
    Ognibene E, Middei S, Daniele S, Adriani W, Ghirardi O, Caprioli A, Laviola G.
    Behav Brain Res; 2005 Jan 30; 156(2):225-32. PubMed ID: 15582108
    [Abstract] [Full Text] [Related]

  • 11. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
    Ambrée O, Richter H, Sachser N, Lewejohann L, Dere E, de Souza Silva MA, Herring A, Keyvani K, Paulus W, Schäbitz WR.
    Neurobiol Aging; 2009 Aug 30; 30(8):1192-204. PubMed ID: 18079024
    [Abstract] [Full Text] [Related]

  • 12. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.
    Reiserer RS, Harrison FE, Syverud DC, McDonald MP.
    Genes Brain Behav; 2007 Feb 30; 6(1):54-65. PubMed ID: 17233641
    [Abstract] [Full Text] [Related]

  • 13. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease.
    Lovasic L, Bauschke H, Janus C.
    Genes Brain Behav; 2005 Apr 30; 4(3):197-208. PubMed ID: 15810906
    [Abstract] [Full Text] [Related]

  • 14. Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
    Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Dyrks T, Thiele A, Heneka MT.
    Neurochem Int; 2010 Nov 30; 57(4):375-82. PubMed ID: 20144675
    [Abstract] [Full Text] [Related]

  • 15. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
    Bonardi C, de Pulford F, Jennings D, Pardon MC.
    Behav Brain Res; 2011 Sep 12; 222(1):89-97. PubMed ID: 21440575
    [Abstract] [Full Text] [Related]

  • 16. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Stover KR, Brown RE.
    Behav Brain Res; 2012 May 16; 231(1):75-85. PubMed ID: 22409975
    [Abstract] [Full Text] [Related]

  • 17. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M, Chiba T, Yamada M, Miyamae-Kaneko M, Matsuoka M, Nakahara J, Tomita T, Iwatsubo T, Kato S, Aiso S, Nishimoto I, Kouyama K.
    Eur J Neurosci; 2004 May 16; 19(10):2826-38. PubMed ID: 15147316
    [Abstract] [Full Text] [Related]

  • 18. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.
    Neuroscience; 2006 Nov 03; 142(4):941-52. PubMed ID: 16938404
    [Abstract] [Full Text] [Related]

  • 19. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
    Toledo EM, Inestrosa NC.
    Mol Psychiatry; 2010 Mar 03; 15(3):272-85, 228. PubMed ID: 19621015
    [Abstract] [Full Text] [Related]

  • 20. Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease.
    Filali M, Lalonde R.
    Brain Res; 2009 Oct 06; 1292():93-9. PubMed ID: 19643098
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.